HFG Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$493K Buy
2,015
+353
+21% +$82.2K 0.35% 63
2025
Q4
$344K Buy
1,662
+348
+26% +$68.8K 0.25% 70
2025
Q3
$244K Buy
+1,314
New +$225K 0.18% 87
2023
Q4
Sell
-2,966
Closed -$462K 108
2023
Q3
$462K Buy
2,966
+302
+11% +$49.8K 0.51% 49
2023
Q2
$441K Buy
2,664
+25
+0.9% +$4.04K 0.47% 50
2023
Q1
$409K Sell
2,639
-40
-1% -$6.46K 0.47% 51
2022
Q4
$473K Buy
2,679
+600
+29% +$104K 0.56% 44
2022
Q3
$340K Buy
2,079
+143
+7% +$24.2K 0.47% 48
2022
Q2
$344K Hold
1,936
0.46% 50
2022
Q1
$343K Buy
1,936
+421
+28% +$71.6K 0.39% 50
2021
Q4
$259K Buy
+1,515
New +$248K 0.29% 65

Other funds holding JNJ

HFG Advisors's JNJ Position: Q1 2026 in Review

HFG Advisors increased its Johnson & Johnson (JNJ) stake by 21% in Q1 2026, buying an estimated $82.2K and bringing the position to 2,015 shares worth $493K. The position accounts for 0.35% of the portfolio, ranked #63.

HFG Advisors first reported a position in JNJ in Q4 2021 and has held it in 11 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • HFG Advisors held 2,015 shares of Johnson & Johnson worth $493K as of Q1 2026.
  • HFG Advisors bought 353 Johnson & Johnson shares in Q1 2026, an estimated $82.2K.
  • Johnson & Johnson made up 0.35% of HFG Advisors's portfolio in Q1 2026, its #63 holding.
  • HFG Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 11 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on HFG Advisors's 13F filing for Q1 2026, filed 8 May 2026.